Summaries for patients. Hormonal testing and pharmacologic treatment of erectile dysfunction.
D000075202:Contraindications; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5 / Q000009:adverse effects / Q000627:therapeutic use*; D007172:Erectile Dysfunction / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology; D020249:Hormone Replacement Therapy / Q000009:adverse effects; D006801:Humans; D006966:Hyperprolactinemia / Q000150:complications / Q000175:diagnosis; D007006:Hypogonadism / Q000150:complications / Q000175:diagnosis; D008297:Male; D017410:Practice Guidelines as Topic; D011388:Prolactin / Q000097:blood; D013739:Testosterone / Q000097:blood / Q000172:deficiency / Q000627:therapeutic use*
D013739:Testosterone; D011388:Prolactin; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5